Android app Apple app link

Dyne Therapeutics, Inc. (DYN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.96
Day's range
$18.21

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/30/2026 Stifel Nicolaus Paul Matteis $37.00 $16.18   128.75%
09/30/2026 Jefferies Andrew Tsai $50.00 $16.21   208.45%
09/29/2026 Piper Sandler Edward Tenthoff $47.00 $16.15   191.02%
09/09/2026 Robert W. Baird Brian Skorney $26.00 $20.31   28.02%
09/08/2026 Raymond James Michael Freeman $37.00 $20.47   80.75%
08/17/2026 H.C. Wainwright Andrew Fein $50.00 $25.70   94.55%
03/02/2026 Chardan Capital Keay Nakae $38.00 $16.15   135.29%
03/02/2026 Morgan Stanley Michael E Ulz $47.00 $15.68   199.74%
12/15/2025 Evercore ISI Gavin Clark-Gartner $36.00 $19.51   84.49%
12/09/2025 Tudor Pickering William Pickering $23.00 $19.09   20.48%
12/08/2025 Morgan Stanley Michael E Ulz $50.00 $22.20   125.23%
12/08/2025 Robert W. Baird Brian Skorney $30.00 $23.03   30.29%
12/08/2025 H.C. Wainwright Andrew Fein $60.00 $23.52   155.14%
12/08/2025 Raymond James Michael Freeman $40.00 $23.38   71.09%
11/06/2025 Evercore ISI Gavin Clark-Gartner $38.00 $18.79   102.24%
08/25/2025 Raymond James Strong Buy $35.00 $13.00   169.23%
06/02/2025 Oppenheimer Andreas Argyrides $34.00 $12.70   167.72%
08/14/2024 Morgan Stanley Michael Ulz $52.00 $43.64   19.16%
08/13/2024 Piper Sandler Edward Tenthoff $53.00 $43.07   23.06%
06/24/2024 Jefferies Eun Yang $42.00 $35.94   16.86%
06/17/2024 Oppenheimer Francois Brisebois $55.00 $32.15   71.07%
05/21/2024 Chardan Capital Keay Nakae $42.00 $35.38   18.71%
05/20/2024 H.C. Wainwright Andrew Fein $48.00 $33.83   41.91%
05/20/2024 Stifel Nicolaus Paul Matteis $41.00 $27.68   48.12%
04/30/2024 Morgan Stanley Michael Ulz $40.00 $25.46   57.11%
09/06/2022 Piper Sandler Edward Tenthoff $23.00 $11.60   98.28%
07/12/2022 Piper Sandler Edward Tenthoff $17.00 $9.03   88.26%

Dyne Therapeutics Inc FAQ's

Dyne Therapeutics Inc has been rated by research analysts at Stifel Nicolaus, H.C. Wainwright, Jefferies, Piper Sandler, Morgan Stanley, RBC Capital in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.